Stocks on the Move - PTSC, POZN, GSK, VNGM
Winston-Salem 4/16/2008 02:24 PM GMT (TransWorldNews)
To register for the Free SmallCapReview Newsletter and automatically be entered to win a Blackberry Pearl visit http://www.smallcapreview.com/subscribe.htm
Patriot Scientific (OTCBB: PTSC) Trading at $0.37, Up $0.02. Announced yesterday after the close that the company’s share repurchase plan has resumed and from time to time will be buying back its stock in the open market. As part of the stock buyback program and prior to the trading restriction that occurred during the nine months ended February 29, 2008, the company repurchased 5,698,821 shares of its outstanding common stock in the open market at an aggregate cost of $3,042,921.
What They Do: Patriot Scientific is a leading intellectual-property licensing company that develops, markets, and enables innovative technologies that satisfy the demands of fast-growing markets for wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more.
How They Trade: PTSC has a 52 week high of $0.94 and a 52 week low of $0.26. Volume averages approximately 1.2M shares a day.
POZEN (Nasdaq: POZN) trading at $13.99, Up $3.46. Today announced along with GlaxoSmithKline (NYSE: GSK) that the FDA has approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines pioneered by GSK, and an anti-inflammatory pain reliever in a single tablet.
What They Do: POZEN, Inc., a development stage company, focuses on the development of products for the treatment of acute and chronic pain, and other pain-related conditions. The company is also exploring the development of product candidates in other pain-related therapeutic areas. Its principal product candidate, Trexima, is being developed in collaboration with GlaxoSmithKline for the acute treatment of migraine. Trexima is a proprietary single tablet containing sumatriptan succinate and naproxen sodium.
How They Trade: POZN has a 52 week high of $19.75 and a 52 week low of $8.29. Volume averages approximately 454K shares a day.
Vanguard Minerals Corporation (OTCBB: VNGM) Trading at $0.68. Up $0.01. Today announced it has retained the services of K-6 Consulting Ltd. of Calgary, Alberta to prepare for and conduct Vanguard’s upcoming exploration programs on its Killock Bay and LeDrew Lake uranium prospects in Northern Saskatchewan. K-6 Consulting Ltd. is headed up by Mr. Edward Kruchkowski, a professional geologist and consultant with 35 years experience throughout North and South America.
What They Do: Vanguard Minerals Corp is a resource exploration company based in Seattle, Washington, USA, committed to the strategic acquisition and exploration of uranium projects. The company's prime focus currently rests in several prospective holdings in proximity to the world's most productive uranium deposits in Western Canada.
How They Trade: VNGM has a 52 week high of $0.78 and a 52 week low of $0.08. Volume averages approximately 162K shares a day.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com has been a leading site for news on small-cap stocks since 1999. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select small-cap stocks, to register and automatically be entered to win a Free Blackberry Pearl visit http://www.smallcapreview.com/subscribe.htm
editor@smallcapreview.com
www.smallcaprteview.com
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
gsk
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
